STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

Camrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival ...

Cancer treatment is becoming increasingly personalised and oncologists know their enemy in more intimate detail than ever ...

A new study has opened in Manchester which could improve screening and early detection of lung cancer for high-risk Hodgkin ...

Supporters who mistakenly thought a new law eliminated a costly barrier to breast cancer diagnostic screening in cancer-prone Iowa feel misled.

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

Women with a rare type of ovarian cancer have prolonged survival after receiving immune-checkpoint blockade if their tumour cells carry a mutation in the gene PPP2R1A.

Compassionate-use lurbinectedin demonstrates modest yet consistent efficacy and is well tolerated in patients with ...

The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the ...

A friend of mine was recently diagnosed with a melanoma, an aggressive form of skin cancer that had spread throughout their ...

The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...